Characteristics and Survival of Patients With Colonic Compared to Rectal Neuroendocrine Tumors: A SEER Registry Analysis
Journal of Surgical Oncology · 29.10.2026
DOI: 10.1002/jso.70440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 29.10.2026. Verfasst von Samantha Sipe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic, Weston, Florida, USA. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
Colon and rectal neuroendocrine tumors (NETs) have varying disease behaviors, presentations, and outcomes. Rectal NETs are detected early; colonic NETs present later and more aggressively. We compared demographic, tumor, treatment, and survival characteristics of colonic versus rectal NETs.
Methods
This retrospective cohort study used SEER data (2000–2022) to identify adults with colonic or rectal NETs. Demographic, tumor, and treatment characteristics were compared by tumor site. Five‐year overall survival (OS) and cancer‐specific survival (CSS) were analyzed using Kaplan–Meier statistics and multivariable Cox proportional hazards regression. Additional site‐specific analyses evaluated stage and treatment patterns by race, ethnicity, and household income.
Results
Twenty‐four percent of 30 246 patients had colonic NETs, and 76.0% had rectal NETs. Rectal NET patients were younger (55.7 vs. 62.9 years, p < 0.001) and more often Black, Asian, or Hispanic. Colonic NETs were more frequently poorly differentiated (43.9% vs. 7.0%), larger (median 30 vs. 5 mm), and more likely to have liver metastases (27.7% vs. 3.7%). Rectal NETs underwent local excision (92.1%), colonic NETs required colectomy (72.3%). Rectal NETs demonstrated higher 5‐year OS (88.8% vs. 55.8%) and CSS (93.8% vs. 58.2%, p < 0.001). Stage III colonic NETs had higher CSS than rectal NETs (67.3% vs. 53.5%, p < 0.001).
Conclusion
Colonic and rectal NETs have distinct clinicopathologic profiles, treatment patterns, and stage‐specific outcomes. These findings support site‐specific evaluation while emphasizing the importance of stage and tumor biology in prognosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic, Weston, Florida, USA.
- Department of General Surgery, College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.
- General Surgery Department, Colorectal Surgery Unit, Mansoura University Hospitals, Mansoura, Egypt.
- Department of Colorectal Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.
ORCID-Profile: Christopher Lopez, Sameh Hany Emile, Abel Abraham, James Burns, Anjelli Wignakumar, Steven D Wexner
Zitieren
APA
Sipe, S., Lopez, C., Emile, S. H., Abraham, A., Burns, J., Wignakumar, A., & Wexner, S. D. (2026). Characteristics and Survival of Patients With Colonic Compared to Rectal Neuroendocrine Tumors: A SEER Registry Analysis. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70440
Vancouver
Sipe S, Lopez C, Emile SH, Abraham A, Burns J, Wignakumar A, et al. Characteristics and Survival of Patients With Colonic Compared to Rectal Neuroendocrine Tumors: A SEER Registry Analysis. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70440
BibTeX
@article{Sipe2026,
author = {Sipe, Samantha and Lopez, Christopher and Emile, Sameh Hany and Abraham, Abel and Burns, James and Wignakumar, Anjelli and Wexner, Steven D},
title = {Characteristics and Survival of Patients With Colonic Compared to Rectal Neuroendocrine Tumors: A SEER Registry Analysis},
journal = {Journal of Surgical Oncology},
year = {2026},
doi = {10.1002/jso.70440}
}
EUVIMED